Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Will DOE Funding Accelerate Lithium Americas' Thacker Pass Buildout?
Will DOE Funding Accelerate Lithium Americas' Thacker Pass Buildout?

Lithium Americas Corp. LAC recently reached a major milestone in the development of its Thacker Pass project and secured the first drawdown of $435 million from the U.S. Department of Energy’s

Quanta vs. Fluor: Which Infrastructure Stock Has More Upside?
Quanta vs. Fluor: Which Infrastructure Stock Has More Upside?

The engineering and construction landscape within the energy-infrastructure sector is undergoing a meaningful shift as utilities, data-center operators and industrial customers rush to expand

Why Costco Stock May Struggle Even as Its Business Thrives: https://www.marketbeat.com/logos/articles/med_20251120233524_blobid0.png
Why Costco Stock May Struggle Even as Its Business Thrives

Now that Walmart Corp (NYSE: WMT) has reported a blowout quarter, investors’ eyes are turning to Costco Wholesale Club Inc. (NASDAQ: COST) to see if it can break out of its year-long funk

FCEL Stock Outperforms Industry Past 3 Months: How to Play?: https://staticx-tuner.zacks.com/images/default_article_images/default282.jpg
FCEL Stock Outperforms Industry Past 3 Months: How to Play?

FuelCell Energy’s FCEL shares have gained 47.5% in the past three months, outperforming the Zacks Alternative Energy – Other industry’s rise of 3.5%. The company also outpaced the Zacks Oil-Energy

Distillate Deficit: How DINO is Positioned to Profit From Strong Margins
Distillate Deficit: How DINO is Positioned to Profit From Strong Margins

HF Sinclair Corporation DINO is a well-known operator of refineries located in Wyoming, Oklahoma, Washington, New Mexico, Utah and Kansas. On its third-quarter earnings call, DINO expressed optimism

NIO Gears Up to Report Q3 Earnings: Here's What to Expect
NIO Gears Up to Report Q3 Earnings: Here's What to Expect

NIO Inc. NIO is slated to release third-quarter 2025 results on Nov. 25, before market open. The Zacks Consensus Estimate for the to-be-reported quarter’s loss per American Depositary Share (ADS)

Altria Narrows 2025 EPS Outlook: Is Margin Growth Peaking?
Altria Narrows 2025 EPS Outlook: Is Margin Growth Peaking?

Altria Group, Inc.’s (MO) move to narrow its 2025 adjusted earnings per share outlook to $5.37-$5.45, up slightly at the low end from the previous $5.35-$5.45 on its latest earnings call, reflects

Pre-markets Up After Week of Tech Selloffs: https://staticx-tuner.zacks.com/images/articles/main/67/133455.webp
Pre-markets Up After Week of Tech Selloffs

Monday, November 24, 2025Pre-market futures are up this hour in what is widely expected to be a less-turbulent week of trading — and a shortened one, at that. Friday’s trading hit the one-month lows

Carnival vs. Royal Caribbean: Which Cruise Stock Is the Better Buy Now?
Carnival vs. Royal Caribbean: Which Cruise Stock Is the Better Buy Now?

Carnival Corporation & plc CCL and Royal Caribbean Cruises Ltd. RCL remain two dominant forces steering the global cruise industry’s recovery, each capitalizing on resilient travel demand and record

3 Stocks to Watch From the Thriving Water Supply Industry
3 Stocks to Watch From the Thriving Water Supply Industry
The companies under the Zacks Utility - Water Supply industry work around the clock to provide a reliable supply of clean drinking water and efficient sewer services to millions of people across the
Will EMCOR's U.K. Exit Unlock Faster Growth Across the Core US?
Will EMCOR's U.K. Exit Unlock Faster Growth Across the Core US?

EMCOR Group, Inc. EME announced the divestiture of its U.K. Building Services segment in September 2025, which is expected to be complete by the end of 2025, upon U.K. regulatory approval. The

Can ChatGPT-Powered Shopping Drive Target's Next Digital Push?
Can ChatGPT-Powered Shopping Drive Target's Next Digital Push?

Target Corporation TGT is rapidly expanding its use of generative AI to boost digital engagement and drive growth. In the third quarter of fiscal 2025, digital comparable sales rose 2.4% and

3 Goldman Sachs Mutual Funds to Buy for Dependable Returns
3 Goldman Sachs Mutual Funds to Buy for Dependable Returns

Goldman Sachs Asset Management (GSAM) is a world-renowned company that has been providing investment management, portfolio design and advisory services to individual and institutional investors

Delek US Holdings Stock: Not a Buy Yet, But Still Worth Holding On
Delek US Holdings Stock: Not a Buy Yet, But Still Worth Holding On

Delek US Holdings, Inc. DK has clearly outperformed its peers, the Refining & Marketing oil and gas sub-industry (ZSI128M) and the broader Oils & Energy sector in the year-to-date period. While the

CELH Strengthens Its Portfolio With Alani Nu: Will 2026 Keep the Pace?
CELH Strengthens Its Portfolio With Alani Nu: Will 2026 Keep the Pace?

Celsius Holdings, Inc.’s CELH acquisition and expansion of Alani Nu in 2025 have significantly accelerated its growth trajectory. Acquired on April 1, 2025, the brand delivered a record

MongoDB (MDB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
MongoDB (MDB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

MongoDB (MDB) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended October 2025. This widely-known consensus outlook gives a

Simulations Plus (SLP) Reports Next Week: Wall Street Expects Earnings Growth
Simulations Plus (SLP) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Simulations Plus (SLP) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended August 2025. This widely-known consensus

Best-Performing ETFs of Last Week: Healthcare Rules
Best-Performing ETFs of Last Week: Healthcare Rules

Wall Street was downbeat last week. The S&P 500 index lost 1.95%, the Dow Jones index retreated 1.9% and the Nasdaq Composite slumped 2.7%. Overvaluation concerns in the artificial intelligence (AI)

Best Momentum Stocks to Buy for Nov. 24
Best Momentum Stocks to Buy for Nov. 24

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Nov. 24:

Pediatrix Medical Group, Inc. MD: This company that delivers newborn care

Wall Street Analysts See a 51.15% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High?
Wall Street Analysts See a 51.15% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High?

Liquidia Corporation (LQDA) closed the last trading session at $29.11, gaining 30.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Wall Street Analysts Think LATAM (LTM) Could Surge 25.15%: Read This Before Placing a Bet
Wall Street Analysts Think LATAM (LTM) Could Surge 25.15%: Read This Before Placing a Bet

LATAM (LTM) closed the last trading session at $45.33, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Profound Medical (PROF) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Profound Medical (PROF) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

The price trend for Profound Medical (PROF) has been bearish lately and the stock has lost 12.3% over the past week. However, the formation of a hammer chart pattern in its last trading session

Wall Street Analysts Believe MediaAlpha (MAX) Could Rally 34.32%: Here's is How to Trade
Wall Street Analysts Believe MediaAlpha (MAX) Could Rally 34.32%: Here's is How to Trade

MediaAlpha, Inc. (MAX) closed the last trading session at $11.86, gaining 3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect?
Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect?

vTv Therapeutics (VTVT) closed the last trading session at $29.56, gaining 41.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Bears are Losing Control Over Veritone (VERI), Here's Why It's a 'Buy' Now
Bears are Losing Control Over Veritone (VERI), Here's Why It's a 'Buy' Now

A downtrend has been apparent in Veritone, Inc. (VERI) lately. While the stock has lost 7.9% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last